Foot Blog News this Week- Issue 7



David G. Armstrong, DPM, PhD Keynote Speaker in Spain:  Amputations Worse Than Cancer


Medical News Today – The Spanish National Symposium on the Diabetic Foot last week was the scene for a keynote address that delivered a strong message proposing “a marriage of technology with common sense for the next decade.” The address was delivered by David G. Armstrong, DPM, PhD, Professor of Surgery and Associate Dean at Scholl College at Rosalind Franklin University. More than 500 specialist physicians, surgeons, and healthcare providers packed a standing-room-only lecture hall in historic Toledo, Spain, to hear Dr. Armstrong’s keynote address. “I believe that the outpouring of interest in this area is emblematic of the importance of the problem,” noted Dr. Armstrong. 

Read more . . .



One Step Closer To A Potential Cure For Diabetes 


Medical News Today – For the millions of people worldwide who are afflicted with diabetes, we are now one step closer to a potential cure for the disease.

Spring Point Project, a non-profit organization created to expedite the widespread availability of islet tissue for diabetes care, has now conducted the first animal population of its biosecure animal facility in Western Wisconsin to breed and maintain high-health, pathogen-free pigs. Insulin-producing islet cells from such high-health pigs are needed to meet the demands in the diabetes community that cannot be realized by using transplantation of human islets. 
 

Read more . . .



Orthocrat Demonstrates Traumacad 2.0 At AAOS – New Version Brings Upgraded Foot, Spine, Hip, Trauma, And Reporting Features


Medical News Today — TraumaCad by Orthocrat, the industry’s leading digital orthopedic surgical planning solution, will showcase the latest upgrades to its dynamic TraumaCad software at the American Academy of Orthopaedic Surgeons (AAOS) conference.  TraumaCad 2.0 offers enhanced surgical planning options for orthopedic procedures. It expands upon the feature-rich, user-friendly, Web-based functionality of the original version by offering surgeons additional resources that enable more thorough and accurate planning of foot, spine, hip, and trauma surgeries. The new version also provides more reporting options.

Read more . . .  


New Congress To Hear From Advocates For Legislation Affecting 46 Million Americans With Arthritis

Medical News Today- A record number of Arthritis Foundation advocates will converge on Capitol Hill February 27 and 28, and urge the U.S. Congress to support the Arthritis Prevention, Control and Cure Act (S. 626) introduced last week. It is the first comprehensive federal response to the burden of arthritis in more than 30 years. Advocates also will encourage Congress to invest now in biomedical research and public health strategies, and increase efforts to confront a disease that affects 46 million Americans, including 300,000 children.
 

Read more . . .



Significant Phase III Results With CIMZIA(TM) In Rheumatoid Arthritis – Radiographic Data Demonstrated Significant Reduction In Joint Damage



Medical News Today-UCB today announced key results of a pivotal Phase III study (RAPID 1) involving nearly 1,000 patients on CIMZIA(TM) (certolizumab pegol), the first PEGylated, Fc-free anti-TNF, intended for the treatment of moderate to severe rheumatoid arthritis (RA). RAPID 1’s radiographic data showed that CIMZIA(TM) in combination with methotrexate prevented structural damage of the joints to a significantly greater degree than placebo plus methotrexate after one year’s treatment.

 Read more . . .



Bone’s Proactive Arthritis Drug Attacks The Cause Of Arthritic Pain


Medical News Today -Bone Medical Limited’s (ASX-BNE) revolutionary rheumatoid arthritis drug, which attacks the cause of sufferers’ pain rather than dealing with the resultant pain, is to undergo advanced testing in the state-of-the-art facility at London’s world-renowned Kennedy Institute of Rheumatology. 

Read more . . .



Vancomycin linked to Thrombocytopenia



WASHINGTON (Reuters) – An antibiotic often used in hospital intensive care units to treat serious staph infections resistant to other medicines may cause a sometimes-fatal bleeding condition, researchers said on Wednesday.

A study in the New England Journal of Medicine linked the antibiotic vancomycin to a disorder called thrombocytopenia.

It is associated with abnormal bleeding and marked by a decrease in blood platelets — cells that help the blood to clot.

 Read more . . .


Gene Therapy Shows Promise As Treatment For Diseased Limbs

Medical News Today
- New research suggests that gene therapy is a safe treatment method to explore in patients whose lower limbs are at risk for amputation because of poor circulation caused by blocked blood vessels.In a Phase I clinical trial, almost half the patients receiving gene therapy reported complete resolution of chronic pain one year after treatment and more than a quarter of patients with chronic wounds experienced complete healing of those ulcers in the same time frame. The results appear online and are scheduled for publication in the March 13 issue of the journal Circulation. 

 Read more . . .


Diabetes Will Be A Bigger Burden Than Predicted, The Lancet

The Lancet
- WHO has predicted a 39% rise in the worldwide prevalence of diabetes between 2000 and 2030, but an Article in this week’s Lancet indicates that this figure might be a gross underestimation.Using populationbased data from Ontario, Lorraine Lipscombe and colleagues have observed a 69% increase in the prevalence of known diabetes from 1995 to 2005; an increase that already exceeds WHO’s predicted rate.

Read more . . .



 Nail changes occur while on docetaxel—a neglected side effect and nuisance Journal Reports



Journal of Supportive Care in Cancer: -WIn this months journal of Supportive Care in Cancer, a study reports that women taking the cytotoxic drug docetaxel for metatastic breast cancer reported changes to their nails.  Fifty-eight percent had some degree of nail changes and an increase to 88.5% was seen after three additional cycles. A large proportion of the patients experienced the nail changes as a cosmetic nuisance, and more than 32% had functional problems.  They concluded that nail changes occur more frequently than previous studies have shown. Furthermore, the study indicates that the nail changes are affecting a large proportion of the patients, both cosmetically and functionally, which may lead to a decrease in their quality of life. No significant association was found according to the possible relation between nail changes and fungal infection.

 

Read more . . .



Diabetic News This Week